- P-ISSN 1010-0695
- E-ISSN 2288-3339
- Apply for Authority
- P-ISSN1010-0695
- E-ISSN2288-3339
Article Detail
Home > Article Detail
Effects of GHX02 on Chronic Obstructive Pulmonary Disease Mouse Model
Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2018, v.39 no.4, pp.126-135
https://doi.org/10.13048/jkm.18040
&
(2018). Effects of GHX02 on Chronic Obstructive Pulmonary Disease Mouse Model. Journal of Korean Medicine, 39(4), 126-135, https://doi.org/10.13048/jkm.18040
- Downloaded
- Viewed
Abstract
Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation and irreversible airflow. This study aimed to evaluate the effects of GHX02 in a COPD-induced mouse model. Methods: The COPD mouse model was established by exposure to cigarette smoke extract and lipopolysaccharide which were administered by intratracheal injection three times with a 7 day interval. GHX02 (100, 200, 400 mg/kg) and all other drugs were orally administrated for 14 days from Day 7 to Day 21. Results: GHX02 significantly decreased the neutrophil counts in bronchoalveolar lavage fluid (BALF) and the number of CD4+, CD8+, CD69+, and CD11b+/GR1+ cells in BALF and lung cells. GHX02 also suppressed the secretion of tumor necrosis factor-alpha (TNF-α), interleukin-17A, macrophage inflammatory protein 2 (MIP2), and chemokine (C–X–C motif) ligand 1 (CXCL-1) in BALF and ameliorated the lung pathological changes. Conclusions: Thus, GHX02 effectively inhibited airway inflammation by inhibiting migration of inflammatory cells and expression of pro-inflammatory cytokines. Therefore, GHX02 may be a promising therapeutic agent for COPD.
- keywords
- chronic obstructive pulmonary disease, cigarette smoke, airway inflammation, herbal medicine, GHX02
Reference
1
1. Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy:making progress towards personalised management. The Lancet. 2015;385(9979):1789-98.
2
2. Spurzem JR, Rennard SI. Pathogenesis of COPD. in Seminars in respiratory and critical care medicine 2005. New York:Thieme Medical Publishers. c1994-.
3
3. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 2016;138(1):16-27.
4
4. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. New England Journal of Medicine. 2009;360(23):2445-54.
5
5. Oostwoud L, Gunasinghe P, Seow H, Ye J, Selemidis S, Bozinovski S, et al. Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Scientific reports. 2016;6:20983.
6
6. Caramori G, Casolari P, Giuffrè S, Barczyk A, Adcock I, Papi A. COPD pathology in the small airways. Panminerva medica. 2011;53(1):51-70.
7
7. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal. 2004;23(6):932-46.
8
8. Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. American journal of respiratory and critical care medicine. 2010;182(2):155-62.
9
9. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. The Lancet. 2009;373(9678):1905-17.
10
10. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine. 2007;356(8):775-89.
11
11. George J, Ioannides-Demos LL, Santamaria NM, Kong DC, Stewart K. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Medical Journal of Australia. 2004;181(5):248.
12
12. Lee ES, Han JM, Kim MH, Namgung U, Yeo Y, Park YC. Effects of Inhalable Microparticles of on Chronic Obstructive Pulmonary Disease in a Mouse Model. Journal of Korean Medicine. 2013;34(3):54-68.
13
13. Kim HW, Yang SY, Kim MH, NamGung U, Park YC. Protective effects of Maekmundong-tang on elastase-induced lung injury. The Journal of Korean Medicine. 2011;32.
14
14. Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, et al. Herbal formula, PM014, attenuates lung inflammation in a murine model of chronic obstructive pulmonary disease. Evidence-Based Complementary and Alternative Medicine. 2012;2012.
15
15. Han JM, Yang WK, Kim SH, Park YC. Effects of Sagan-tang and individual herbs on COPD mice model. Herbal Formula Science. 2015;23(2):171-87.
16
16. Lee CW, Yang WK, Lyu YR, Kim SH, Park YC. Effects of Gwaruhaengryeon-hwan on COPD and Particulate Matter Induced Lung Injury on a Mouse Model. The Journal of Internal Korean Medicine. 2017;38(3):353-66.
17
17. Heo J. Dong-Ui-Bo-Gam. Hadong:Donguibogam Publish. 2005:1341.
18
18. Kim OS, Seo CS, Kim Y, Shin HK, Ha H. Extracts of Scutellariae Radix inhibit low-density lipoprotein oxidation and the lipopolysaccharide-induced macrophage inflammatory response. Molecular medicine reports. 2015;12(1):1335-41.
19
19. Guo M, Zhang N, Li D, Liang D, Liu Z, Li F, et al. Baicalin plays an anti-inflammatory role through reducing nuclear factor-κB and p38phosphorylation in S. aureus-induced mastitis. International immunopharmacology. 2013;16(2):125-30.
20
20. Gueders MM, Paulissen G, Crahay C, Quesada-Calvo F, Hacha J, Van Hove C, et al. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflammation research. 2009;58(12):845.
21
21. Mizutani N, Fuchikami JI, Takahashi M, Nabe T, Yoshino S, Kohno S. Pulmonary emphysema induced by cigarette smoke solution and lipopolysaccharide in guinea pigs. Biological and Pharmaceutical Bulletin. 2009;32(9):1559-64.
22
22. Tanaka H, Masuda T, Tokuoka S, Komai M, Nagao K, Takahashi Y, et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflammation Research. 2001;50(12):616-24.
23
23. O’donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax. 2006;61(5):448-54.
24
24. Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626-33.
25
25. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta–analysis. Journal of global health. 2015;5(2).
26
26. Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. American journal of respiratory and critical care medicine. 2013;187(7):721-7.
27
27. Meijer M, Rijkers GT, Van Overveld FJ. Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. Expert review of clinical immunology. 2013;9(11):1055-68.
28
28. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. The Journal of clinical investigation. 2008;118(11):3546-56.
29
29. Prause O, Bossios A, Silverpil E, Ivanov S, Bozinovski S, Vlahos R, et al. IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo–effects of anti-inflammatory pharmacotherapy. Pulmonary pharmacology & therapeutics. 2009;22(3):199-207.
30
30. Caramori G, Adcock IM, Di Stefano A, Chung KF. Cytokine inhibition in the treatment of COPD. International journal of chronic obstructive pulmonary disease. 2014;9:397.
31
31. Van Minh C, Nhiem NX, Yen HT, Van Kiem P, Tai BH, Anh HLT, et al. Chemical constituents of Trichosanthes kirilowii and their cytotoxic activities. Archives of pharmacal research. 2015;38(8):1443-8.
32
32. Chang HK, Yang HY, Lee TH, Shin MC, Lee MH, Shin MS, et al. Armeniacae semen extract suppresses lipopolysaccharide-induced expressions of cycloosygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial cells. Biological and Pharmaceutical Bulletin. 2005;28(3):449-54.
33
33. Yokozawa T, Ishida A, Cho EJ, Kim HY, Kashiwada Y, Ikeshiro Y. Coptidis Rhizoma:protective effects against peroxynitrite‐induced oxidative damage and elucidation of its active components. Journal of pharmacy and pharmacology. 2004;56(4):547-56.
34
34. Kim JM, Jung HA, Choi JS, Lee NG. Identification of anti-inflammatory target genes of Rhizoma coptidis extract in lipopolysaccharide-stimulated RAW264. 7 murine macrophage-like cells. Journal of Ethnopharmacology. 2010;130(2):354-62.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations
Other articles from this issue
- Effect of acupuncture on short-term memory and apoptosis after transient cerebral ischemia in gerbils
- Hypothesis Proposal about Predictive Factors and Optimal Age for Response to Herbal Medicine Treatment for Height Gain in Children: a Retrospective Review
- Development of an Evidence-Based Clinical Practice Guideline of Korean Medicine for Stroke: A Study Protocol
- Kyungheechunggan-tang suppresses inflammatory cytokines and fibrotic genes in LPS-induced RAW 264.7 cells and LX-2 cells
- Customized BMI and waist circumference cut-off values are needed to identify metabolic syndrome among South Koreans according to their Sasang constitutional type
- A Study on the Effectiveness of Herbal Medicine Treatment for 755 Traffic Accident Patients-A Retrospective Review According to the Type of Herbal Medicine Prescription
- Efficacy of Hataedock Treatments for Maintenance and Formation of Lipid Barrier in Obese NC/Nga Mice with Dermatophagoides Farinae-Induced Atopic Dermatitis
- Anti-osteoarthritic effects of a combination of pomegranate concentrate powder, Eucommiae cortex and Achyranthis radix in rats
- Analysis of Medical Disputes in Korean Medicine : With a focusing on Korean medicine treatments in Korean Acupuncture & Moxibustion Medicine Society official documents
- Study on Hand Greater Yang Skin from the Viewpoint of Human Anatomy
- Effects of GHX02 on Chronic Obstructive Pulmonary Disease Mouse Model
- Systematic Review of Case Reports about Korean Medicine for Lung Cancer
- A Comparative Study of Korean mistletoe lectin and bee venom on mechanism in inducing apoptosis of Hep G2, a liver cancer cell
- Successful Outcome of an Elderly Patient with Small Cell Lung Cancer with only Alternative Treatments: A Case Report
- Successful Outcome of Breast Cancer Patient Refusing Conventional Treatments: A Case Report
- Seven Cases of Wart treated with MY1-Hwan
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.